International Network on Health and Hepatitis in Substance Users (INHSU)

We’re looking for a proactive and organised Project Officer to help us plan, implement, and monitor impactful projects to improve the health and wellbeing of people who use drugs. Is it you? Find out more in the link below (must be based in Australia): https://lnkd.in/g3yEK56V

Join #INHSUEMCR and UNAIDS for this free webinar and discover: ➡️ How UNAIDS data drives global HIV targets ➡️ Career & collaboration opportunities Don’t miss this chance to gain valuable insights to advance your research and career. Register here: https://lnkd.in/gi67mtW4 

Only a few places remaining for INHSU's HCV Intervention Symposium, to be held in Atlanta on November 22. Learn more and sign up at https://lnkd.in/gwUCva4i

Join #INHSUEMCR and EUDA for this free webinar and discover: ➡️How the European Union Drugs Agency (EUDA)'s data shapes global drug policy ➡️Career & collaboration opportunities Don’t miss this chance to gain valuable insights to shape your research and career. Register here: https://lnkd.in/gkX4ENc7

We are lucky each year to have the CATIE team in attendance at the conference, not only sharing their work, but capturing key insights and takeaways from speakers and delegates.

At the opening ceremony of #INHSU2024 in Athens, Philip Bruggmann, from the Arud Centre for Addiction Medicine in Switzerland and co-founder of INHSU, was welcomed to the stage for the first-ever Philip Bruggmann Lecture Award. In his heartfelt speech, he reflected on the early days of INHSU, sharing the organisation's journey and unveiling the new award, which will celebrate innovation and leadership within the network. Dr. Buggmann reminisced about the challenging start of advocating for the treatment of people who inject drugs, which was met with scepticism and even outright hostility. "The guidelines said no, you should not treat people who use drugs. Starting research into it, I felt lonely in my country," he said. However, through his determination and the support of like-minded colleagues, in 2009, a small meeting in Zurich transformed into a symposium with over 180 attendees from 30 countries, which then led to the formation of INHSU as an organisation. It was a pivotal moment that eventually influenced many changes, including the removal of restrictions preventing the treatment of people who use drugs living with HCV from EASL guidelines in 2015. Dr. Bruggmann encouraged the audience to take action when they saw a need. "Start the project if you see a need. There will always be doubters—don’t listen. It doesn’t need to be perfect," he said. Find out more about the award https://lnkd.in/eiuF_shS

Launched today at #INHSU2024 by #INHSUPrisons: A new toolkit to amplify advocacy for prison-based HCV testing, treatment, & prevention. Whether you're starting out or need ready-made resources, this toolkit has everything you need: https://lnkd.in/gF-S2M-t #EndHepCinPrisons

The countdown is on! But we'll see a lot of our network even sooner - at Policy Day, Community Day or the Prisons Workshop. Find out more about our pre-conference events here: https://lnkd.in/dsspbWQp

Less than one week to go until #INHSU2024 in Athens! Have you started planning yet? What session or speaker are you most looking forward to? View the program here: https://lnkd.in/guJqNiv9

We're just one week away from #INSHU 2024, where we'll welcome hundreds of delegates dedicated to improving the health and well-being of people who use drugs. Comment below to let us know what you're most looking forward to👇